Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Zinc Supplementation on Botulinum Toxin for Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT07405554 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT07405554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07405554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Zinc Supplementation on Botulinum Toxin for Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Endeavor Health
Phase
Phase 2
Overall status
Recruiting
Start date
February 26, 2026
Completion date
December 31, 2026
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab)